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Abstract
A major difficulty of producing induced pluripotent stem cells (iPSCs) has been the low efficiency of reprogramming
differentiated cells into pluripotent cells. We previously showed that 5% of mouse embryonic fibroblasts (MEFs) were
reprogrammed into iPSCs when they were transduced with a fusion gene composed of Oct4 and the transactivation domain
of MyoD (called M3O), along with Sox2, Klf4 and c-Myc (SKM). In addition, M3O facilitated chromatin remodeling of
pluripotency genes in the majority of transduced MEFs, including cells that did not become iPSCs. These observations
suggested the possibility that more than 5% of cells had acquired the ability to become iPSCs given more favorable culture
conditions. Here, we raised the efficiency of making mouse iPSCs with M3O-SKM to 26% by culturing transduced cells at low
density in serum-free culture medium. In contrast, the efficiency increased from 0.1% to only 2% with the combination of
wild-type Oct4 and SKM (OSKM) under the same culture condition. For human iPSCs, M3O-SKM achieved 7% efficiency under
a similar serum-free culture condition, in comparison to 1% efficiency with OSKM. This study highlights the power of
combining the transactivation domain of MyoD with a favorable culture environment.
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Introduction
iPSC technology demonstrates that differentiated cells can be
dedifferentiated to a pluripotent state by introducing onlya few genes,
most commonly the OSKM genes [1,2,3]. However, protocols for
generating iPSCs are inefficient and slow. Generally less than 1% of
transduced cells are reprogrammed to form iPSCs with the standard
OSKM transgenes. This is partly because exogenous Oct4 and Sox2
proteins cannot gain access to their target DNA sequences, perhaps
due to closed chromatin structure [4]. We recently showed that a
fusion gene, called M3O, between Oct4 and the transactivation
domain (TAD) derived from MyoD, a master regulator of skeletal
myogenesis, reprograms 5% of MEFs into iPSCs when combined
with polycistronic SKM [4,5]. Importantly, M3O-SKM remodeled
chromatin at the Oct4 and Sox2 genes to an embryonic stem cell
(ESC)-like state in the majority of MEFs, including those that failed to
become iPSCs, as evaluated by binding of Oct4 and Sox2 proteins
and histone modification patterns at the two genes. These findings
indicated that M3O-SKM increased the number of completed iPSCs
as well as the background population of partially reprogrammed
MEFs. Therefore, we speculated that if we could identify an
additional cue that drives the partially reprogrammed population
toward completed iPSCs, the efficiency of making iPSCs would
drastically increase. The current study addressed the question of
whether the culture environment could serve as the additional cue by
changing the density of transduced cells and culture media.
Results and Discussion
We previously used feeder-free and feeder-plus protocols to
make iPSCs with M3O-SKM [4]. With the feeder-free protocol,
3.6% of MEFs transduced with M3O-SKM were reprogrammed
into iPSCs in a culture medium that contained 15% fetal bovine
serum (FBS). In the present study, we replaced FBS with 20%
KnockOut Serum Replacement (KSR), which is optimized for
maintenance of ESCs in an undifferentiated state, although its
contents have not been disclosed (Fig. 1A, Protocol A). KSR has
also been reported to be more effective in making iPSCs than FBS
[6]. In addition, we added the FLAG sequence to the amino
terminus of M3O to create the FM3O construct (Fig. 1B). An anti-
FLAG antibody was used to detect the protein with immunoflu-
orescence staining because commercially available Oct4 antibod-
ies recognized M3O only if the protein was denatured. The FLAG
sequence did not significantly affect the efficiency of making
iPSCs. The FLAG sequence was also attached to Oct4 to prepare
FO as a control. The co-transduction efficiency of FM3O with
SKM and FO with SKM was 87.563.2% and 89.262.3%,
respectively (Fig. 1C). iPSC formation was monitored by
emergence of ESC-like colonies expressing the Oct4-driven GFP
transgene as previously described [4]. GFP-positive colonies first
appeared around day 4 with FM3O-SKM, and many more
colonies arose over the next two days with KSR compared to FBS
(Fig. 1D, top and middle). Colony formation with FM3O-SKM
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and making it impossible to accurately count colonies. In contrast,
colony formation with FO-SKM and KSR was late (day 7) and
inefficient, with less than 0.1% of MEFs becoming iPSCs by day
10 (Fig. 1D, bottom).
To obtain accurate colony numbers, MEFs were seeded at
various lower densities on feeder cells in the presence of KSR
(Fig. 2A, Protocol B). Colonies that emerged on day 5 with FM3O-
SKM were positive for GFP and the relatively specific pluripo-
tency markers SSEA-1 and alkaline phosphatase (Fig. 2B). This
study indicated that seeding transduced MEFs at 2,000 cells/well
of a 12-well plate was most effective in making iPSCs (Fig. 2C). At
this cell density, the number of GFP-positive colonies steadily
increased over ten days, reaching a peak around day 12, when
25.8% of MEFs were reprogrammed to iPSCs with FM3O-SKM
(Fig. 2D). In contrast, FO-SKM induced only 2.3% of cells to
become iPSCs by day 13. Taking transduction efficiency into
account, the net efficiency of making iPSCs was essentially
unchanged at 29.5% (25.8/0.875) for FM3O-SKM and 2.6%
(2.3/0.892) for FO-SKM (Fig. 2C). The current efficiency
obtained with FM3O-SKM was substantially higher than the
previous efficiency of 5.1%, which was obtained at seeding density
of 50,000 cells/well in the presence of FBS [4]. When FBS was
used at cell density of 2,000 cells/well, less than 2% of MEFs were
Figure 1. Formation of mouse iPSCs with FM3O-SKM and FO-SKM without subculture. (A) Schematic drawing of Protocol A. (B) Schematic
drawings of FLAG-tagged Oct4 and FLAG-tagged M3O. Numbers indicate amino acid positions of Oct4 and MyoD. (C) Immunofluorescence staining
of transduced FM3O, FO and Sox2. MEFs were double-immunofluorescence stained with anti-FLAG antibody, which recognized FM3O and FO, and
anti-Sox2 antibody on day 2. DNA was counterstained with Hoechst 33342. Bar, 100 mm. (D) Appearance and increase of GFP-positive colonies after
transduction with FM3O-SKM and FO-SKM into MEFs. While iPSC medium containing KSR was used in the top and bottom sets, KSR was replaced with
15% FBS in the middle set. Large GFP-positive colonies had fused as early as day 6 with FM3O-SKM and KSR as shown in the top set; however, GFP-
positive areas generally diminished by day 9 when these tightly packed cells were left without subculture. Although less than 10 GFP-positive
colonies appeared by day 9 with FO-SKM and KSR in a well of a 12-well plate, the majority of the areas did not contain GFP-positive colonies as shown
in the bottom set. Bar, 100 mm.
doi:10.1371/journal.pone.0034149.g001
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Thus, KSR and low cell density were the two major factors
responsible for the significant improvement of iPSC production in
the current study in comparison to our previous work [4].
Mechanistic analysis of the effects of cell density on reprogram-
ming efficiency awaits further investigation.
The pluripotency of iPSCs prepared with FM3O-SKM using
Protocol B were evaluated with a standard set of experiments. The
iPSC colonies expressed nine key genes for pluripotency at similar
levels to those in ESCs (Fig. 3A). Three genes highly expressed in
MEFs — Thy1, Col6a2 and Fgf7 — were downregulated to ESC
levels in iPSCs (Fig. 3B). When iPSCs were subcutaneously
injected into NOD/SCID mice, they formed teratomas that
contained tissues derived from all three germ layers (Fig. 3C).
Furthermore, iPSCs formed chimeric mice upon aggregation with
8-cell-stage ICR mouse embryos (Fig. 3D). When one of the
chimeric mice was mated with an ICR female mouse, all six pups
had a brown coat color, proving that the derivatives of iPSCs
contributed to germ cells (Fig. 3E).
To understand if the highly efficient generation of iPSCs using
FM3O-SKM and Protocol B was specific to MEFs, we isolated
myoblasts from adult Oct4-GFP mice (Fig. 4A) and prepared
iPSCs from these cells (Fig. 4B). The co-transduction efficiency
was 92.863.4% for FM3O-SKM and 99.061.5% for FO-SKM
Figure 2. Formation of mouse iPSCs with FM3O-SKM and FO-SKM with subculture onto feeder cells. (A) Schematic drawing of Protocol
B. (B) Expression of GFP and staining of SSEA-1 and alkaline phosphatase in iPSC colonies on day 5. Bar, 100 mm. (C) Efficiency of making iPSCs with
Protocol B at different cell densities. The number of MEFs seeded on feeder cells in a 12-well plate on day 1 is written on the x axis. (D) Formation of
iPSCs from MEFs seeded at 2,000 cells/well of a 12-well plate by using FM3O-SKM and FO-SKM in Protocol B. Mean 6 SEM from three independent
experiments is shown. Maximum efficiency obtained with each gene combination is shown at the bottom. In addition, efficiency was calibrated on
the basis of viral transduction efficiency and described as net efficiency in parentheses.
doi:10.1371/journal.pone.0034149.g002
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PLoS ONE | www.plosone.org 3 March 2012 | Volume 7 | Issue 3 | e34149Figure 3. Verification of pluripotency of iPSCs prepared from MEFs with FM3O-SKM using Protocol B. (A) Quantitative RT-PCR analyses
of pluripotency genes comparing day 10 iPSC colonies and MEFs. The value in ESCs was defined as 1.0 for each gene. Mean+SEM obtained from ten
colonies is shown. (B) Quantitative RT-PCR analyses of MEF-enriched genes comparing iPSCs and ESCs. The value in MEFs was defined as 1.0 for each
gene. Ten colonies were harvested on day 10. (C) Hematoxylin and eosin staining of teratoma sections derived from an iPSC clone after subcutaneous
injection into an NOD/SCID mouse. The arrow and arrowhead indicate striated muscle (mesoderm) and respiratory epithelium (endoderm),
respectively. Bar, 200 mm. (D) Chimeric mice prepared with an iPSC clone. High (right) and low (left) contribution of iPSCs to the skin is shown. The
host 8-cell-stage embryos used to generate mice were derived from the ICR strain with a white coat color. The mottled coat color of the chimeric
mice is due to the fact that iPSCs were derived from 129/B6 mice which displayed a brown or black coat color. (E) Pups obtained from mating the
chimeric mouse on the right in panel D with an ICR female (white mouse shown in this photograph). This result shows that the derivatives of iPSCs
contributed to germ cells.
doi:10.1371/journal.pone.0034149.g003
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staining of myoblasts with anti-MyoD antibody and anti-Pax7 antibodies on day 2. DNA was counterstained with Hoechst 33342. More than 98% of
the cells expressed both MyoD and Pax7, confirming the high purity of myoblasts used to make iPSCs. Bar, 100 mm. (B) Double immunofluorescence
staining of myoblast-derived iPSC colonies on day 30 with antibodies against Oct4 and Nanog. Because transduced Oct4 had already been supressed
by this time point, endogenous Oct4 protein was represented in this result. Bar, 100 mm. (C) Double immunofluorescence staining of myoblasts
transduced with FM3O, FO and Sox2 on day 2. Myoblasts were stained with anti-FLAG antibody (recognizing FM3O and FO) and anti-Sox2 antibody.
Bar, 100 mm. (D) Formation of iPSCs from myoblasts with FM3O-SKM and FO-SKM with Protocol B. Maximum efficiency obtained with each gene
combination is shown at the bottom. The efficiency was calibrated according to the transduction efficiency and reported as net efficiency in
parentheses.
doi:10.1371/journal.pone.0034149.g004
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myoblasts into iPSCs (13.2%, net efficiency was 14.2%, Fig. 4D) as
compared with MEFs; nonetheless, it was substantially more
efficient than our previous result obtained with OSKM in the
presence of KSR and feeder cells (0.0025%) [7].
Because a fusion gene between Oct4 and a fragment of the VP16
TAD (amino acids 446–490) also increased the efficiency of
making iPSCs [8], we fused the same fragment and the full-length
VP16 to Oct4 (called VP16SO and VP16LO, respectively, Fig. 5A).
While these two VP16 fusion genes were indeed much more
efficient than wild-type Oct4, they were still less efficient than M3O
(Fig. 5B). This difference was not due to a difference in viral titers
(Fig. 5C). We also compared the Oct4-fusion genes without c-Myc
because it causes tumor formation in vivo. Although the efficiency
significantly dropped for all these fusion genes, M3O-SK still
induced iPSCs in 3.9% of MEFs (Fig. 5D), which was more
efficient than transduction of wild-type Oct4 in the presence of c-
Myc (FO-SKM, 2.3%, Fig. 2C).
Previously we showed that M3O-SKM induces iPSC formation
from adult human dermal fibroblasts at an efficiency of 0.30% in
feeder-free culture with KSR when seeded at 17,000 cells/well of a
12-well plate, in contrast to 0.0052% with OSKM [4]. Following
the success of Protocol B as described above, we seeded transduced
human neonatal fibroblasts at densities ranging from 1,000 to
17,000 cells/well of a 12-well plate on feeder cells (Fig. 6A). The
number of ESC-like colonies that expressed NANOG and TRA1-
60 were counted as iPSC colonies (Fig. 6B). When transduced
fibroblasts were seeded on feeder cells at 17,000 cells/well,
the efficiency of iPSC formation was raised to 1.7%. However,
as with mouse iPSCs, the highest efficiency was obtained at
2,000 cells/well. At this cell density, iPSC colonies emerged
around day 5 with M3O-SKM and day 8 with OSKM (Fig. 6C,
KSR). The colony number peaked on day 14 with 6.6% of
fibroblasts becoming iPSCs with M3O-SKM, in contrast to 0.8%
on day 16 with OSKM. Two additional serum-free media were
less effective than KSR (Fig. 6C, Pluriton and TeSR1). Cloned
iPSCs prepared with M3O-SKM and KSR also expressed other
pluripotency markers, including SSEA-4, alkaline phosphatase,
NANOG and endogenous OCT4 on day 27 (Fig. 7A). Pluripo-
tency of an iPSC clone established with M3O-SKM and KSR was
verified with teratoma formation (Fig. 7B). In these experiments
we transduced M3O, OCT4, SOX2, KLF4 and c-MYC in separate
viruses. Since KLF4 and c-MYC were endogenously expressed in
fibroblasts [9], transduction efficiency of these genes could not be
determined but transduction efficiency of SOX2 was sufficiently
high (87.0% with M3O-SKM and 88.9% with O-SKM) (Fig. 7C).
In conclusion, the present study shows that the efficiency of
making iPSCs can be drastically raised by changing the culture
medium and the density at which transduced cells are seeded on
feeder cells. A few other studies have achieved comparable
efficiency of making mouse and human iPSCs. For instance, pre-B
cells and myeloid progenitor cells isolated from iPSC-derived mice
were converted to secondary iPSCs at an efficiency of 92% and
27.5%, respectively, after activation of the OSKM transgenes
[10,11]. Another study demonstrated around a 10% efficiency of
preparing mouse and human primary iPSCs (i.e. not from iPSC-
derived differentiated cells) using the miR302/367 cluster [12].
However, to the best of our knowledge, the present study achieved
the highest efficiency of making primary mouse iPSCs with an
OSKM variant. Furthermore, the difference in efficiency between
Figure 5. Comparison of the efficiency of making mouse iPSCs with FM3O, VP16SO and VP16LO using Protocol B. (A) Schematic
drawings of the VP16-tagged Oct4s, called VL16LO and VL16SO. Numbers indicate amino acid positions of VP16. (B) Formation of iPSCs from MEFs
with two VP16-Oct4 fusion genes and SKM. (C) Virus titer of each construct measured with quantitative RT-PCR. Mean 6 SEM from three independent
experiments is shown. (D) Formation of iPSCs from MEFs without c-Myc.
doi:10.1371/journal.pone.0034149.g005
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importance of the transactivation capacity of Oct4 as a major
limiting factor in iPSC formation.
Materials and Methods
Ethics Statement
All animal experiments were approved by the Institutional
Animal Care and Use Committee at the University of Minnesota
(1002A78174).
Preparation of iPSCs from MEFs
The FLAG sequence DYKDDDDK was added to the amino
terminus of M3O and Oct4 to create the FM3O and FO constructs
in the pMXs-IP vector [13]. Full-length (amino acids 411–490)
and the second half (amino acids 446–490) of the VP16 TAD were
fused to the amino terminus of the mouse Oct4 gene in the pMXs-
IP vector to prepare the VP16LO and VP16SO constructs,
respectively. Plat-E cells [14] were seeded at 5610
5 cells/3.5 cm
dish on day 24. Four micrograms of the pMXs-IP vectors
encoding FO, FM3O, VP16LO, VP16SO and polycistronic SKM
were separately transfected into Plat-E cells with 10 ml Lipofecta-
mine 2000 (Invitrogen) on day 23 to prepare virus supernatant.
Virus titer was measured using a Retro-X qRT-PCR titration kit
(Clontech). The medium was replaced with 1.5 ml DMEM with
10% FBS on day 22. MEFs prepared from Oct4-GFP transgenic
mice [15] were seeded at 5610
4 cells/well of a 12-well plate on
day 22 in DMEM with 10% FBS. Virus supernatant was
harvested on day 21 and day 0 and filtered through a 0.45 mm
syringe filter. Two hundred and fifty microliters of each virus
supernatant was added to each well of MEFs with 10 mg/ml
polybrene. In Protocol A, culture medium was changed to iPSC
medium (DMEM, 20% KSR (Invitrogen), 100 mM MEM non-
essential amino acids, 100 mM 2-mercaptoethanol, 2 mM L-
glutamine and 1000 u/ml leukemia inhibitory factor) on day 1,
and cells were maintained without subculture. KSR was replaced
with 15% FBS only in the experiment shown in the middle set of
Fig. 1D. Protocol B was used to measure the efficiency of making
iPSCs. For this protocol, transduced MEFs were subcultured onto
irradiated MEFs at 1,000–4,000 cells/well of a 12-well plate in
iPSC medium containing KSR on day 1. The efficiency of making
iPSCs was calculated each day thereafter by dividing the number
of GFP-positive colonies by the seeded cell number. Net efficiency
was obtained by dividing the above-mentioned efficiency of
making iPSCs by the efficiency of viral co-transduction obtained
with immunofluorescence staining of transduced cells.
Preparation of iPSCs from mouse myoblasts
Satellite cell-derived myoblasts were isolated from the hind
limb skeletal muscle of one-month-old adult Oct4-GFP transgenic
mice as previously described [16]. Myoblasts were cultured on
collagen-coated dishes in myoblast growth medium (HAM’s F-10
medium supplemented with 20% FBS and 5 ng/ml basic
fibroblast growth factor (R&D Systems)) and used to make iPSCs
with Protocol B.
Figure 6. Human iPSC formation from foreskin fibroblasts transduced with M3O-SKM and OSKM. (A) Schematic drawing of the protocol
used to make human iPSCs. (B) Double immunofluorescence staining of human iPSCs with antibodies against NANOG and TRA1-60 on day 8. DNA
was counterstained with Hoechst 33342. Bar, 100 mm. (C) Temporal profiles of iPSC colony formation in three different serum-free media. Transduced
fibroblasts were seeded at 2,000 cells/well of a 12-well plate on feeder cells. Immunostaining of NANOG and TRA1-60 was used to monitor iPSC
colony formation. Highest efficiency is reported at bottom.
doi:10.1371/journal.pone.0034149.g006
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The human M3O fusion gene was composed of the M3 domain
of human MYOD fused to the amino terminus of full-length human
OCT4 cDNA [13]. Human M3O, OCT4, SOX2, KLF4 and c-MYC
(Addgene) were separately inserted into the pMXs-IP vector and
transfected into Plat-A cells (Cell Biolabs) with Lipofectamin 2000
(Invitrogen) on day 23. On day 22, 2.7610
4 foreskin fibroblasts
obtained from a newborn boy (Lonza) were plated in a well of a
12-well plate in DMEM with 10% FBS. Virus supernatant was
harvested from Plat-A cells on day 21 and day 0, filtered through
a 0.45 mm syringe filter, and transduced each day into fibroblasts
with polybrane. Transduced cells were harvested on day 3 with
trypsin and subcultured separately in three different media at
2610
3 cells/well onto irradiated MEFs in 12-well plates. The first
medium (KSR medium) was composed of KnockOut DMEM/F-
12 (Invitrogen), 20% KSR, 100 mM MEM non-essential amino
acids, 1% insulin-transferrin-selenium (Invitrogen), 0.1 mM 2-
mercaptoethanol, 16GlutaMAX (Invitrogen) and 4 ng/ml basic
FGF. Pluriton
TM Reprogramming Medium (Stemgent) and
mTeSRH1 Medium (STEMCELL Technologies) were prepared
Figure 7. Expression of pluripotency markers in cloned human iPSCs and their ability to form teratomas. (A) Alkaline phosphatase
staining and immunofluorescence staining of pluripotency markers in cloned human iPSCs obtained with M3O-SKM on day 27 after four passages.
Bar, 100 mm. (B) Hematoxylin and eosin staining of teratoma sections derived from an iPSC clone after subcutaneous injection into an NOD/SCID
mouse. Bar, 200 mm. (C) Immunofluorescence staining of foreskin fibroblasts with anti-SOX2 antibody on day 2 after transduction of M3O-SKM and
OSKM. Bar, 100 mm.
doi:10.1371/journal.pone.0034149.g007
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without additional components. Culture media were changed
every other day.
Immunofluorescence staining and alkaline phosphatase
staining
iPSCs were fixed with 4% formaldehyde in phosphate buffered
saline for 10 min and treated with 0.5% Triton X-100 for 3 min to
permeabilize the plasma membrane. Cells were then incubated
with primary and secondary antibodies for 1 hr each at 25uC
using the antibodies listed in Table S1. Hoechst 33342 was used to
counterstain DNA. Fluorescence photographs were taken with an
AxioCam charge coupled device camera attached to an Axiovert
200 M fluorescence microscope (all from Carl Zeiss) equipped
with a 106A-Plan Ph1 Var1 objective (numerical aperture 0.25).
Images were processed with Photoshop 7.0 (Adobe Systems).
iPSCs were also stained with an Alkaline Phosphatase Detection
Kit (Millipore SCR004) following the manufacturer’s instructions.
Quantitative RT-PCR (qRT-PCR)
iPSC colonies were individually harvested, and cDNA was
directly prepared from cells with a Cells-to-cDNA II kit (Ambion).
qRT-PCR was performed on a Realplex 2S system (Eppendorf)
with a GoTaq qPCR Master mix (Promega). Primers are listed in
Table S2. The mRNA level of each gene was normalized using the
mRNA encoding glyceraldehyde 3-phosphate dehydrogenase
(GAPDH). The feeder-free ES cell line CGR8 (European
Collection of Cell Cultures) was used as positive control.
Aggregation chimera and teratoma formation
Eight to 10 iPSCs were briefly exposed to acidic Tyrode’s
solution (Millipore) and transferred into a microdrop of KSOMaa
solution (Millipore) that contained a zona-free 8-cell-stage mouse
embryo of the ICR strain (albino). On the next day morula stage
embryos that contained GFP-positive iPSCs were transferred into
the uteri of 2.5 days post-coitum pseudopregnant recipient mice to
obtain chimeric mice. Teratomas were induced by subcutaneously
injecting one million iPSCs into NOD/SCID mice. After four
weeks teratomas were isolated, fixed with 10% formalin, and
embedded in paraffin. Histological sections (5 mm thick) were
stained with haematoxylin and eosin to identify tissue types.
Supporting Information
Table S1 Antibodies used for immunofluorescence
staining.
(DOCX)
Table S2 Primers used for quantitative RT-PCR.
(DOCX)
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